Electrospun matrices for localised controlled drug delivery: Release of tetracycline hydrochloride from layers of polycaprolactone and poly(ethylene-co-vinyl acetate)

Drug Delivery and Translational Research

Volumn 2, Issue 6, 2012, Pages 477-488

  Alhusein, Nour ^a   Blagbrough, Ian S ^a   de Bank, Paul A ^a  

^a University of Bath   (United Kingdom)

Author keywords

Drug delivery; Electrospinning; Multilayer; Nanofibre; Poly(ethylene co vinyl acetate); Polycaprolactone; Tetracycline; Wound dressing

Indexed keywords

ETHYLENE VINYL ACETATE COPOLYMER; NANOFIBER; POLYCAPROLACTONE; TETRACYCLINE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BIOLOGICAL ACTIVITY; CHROMATOPHORE; CONTROLLED DRUG RELEASE; DRUG FORMULATION; ELECTROSPINNING; ENCAPSULATION; FLUORESCENCE; IMMERSION; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; SKIN INFECTION; STAPHYLOCOCCUS AUREUS; SUSTAINED DRUG RELEASE; ULTRAVIOLET RADIATION; WOUND HEALING;

EID: 84869066691     PISSN: 2190393X     EISSN: 21903948     Source Type: Journal    
DOI: 10.1007/s13346-012-0106-y     Document Type: Article

References (51)

1. Liang D, Hsiao BS, Chu B. Functional electrospun nanofibrous scaffolds for biomedical applications. Adv Drug Deliv Rev. 2007; 59: 1392-412. Review.
2. Sill TJ, von Recum HA. Electrospinning: applications in drug delivery and tissue engineering. Biomaterials. 2008; 29: 1989-2006. Review.
3. Meinel AJ, Germershaus O, Luhmann T, Merkle HP, Meinel L. Electrospun matrices for localized drug delivery: current technologies and selected biomedical applications. Eur J Pharm Biopharm. 2012; 81: 1-13. doi: 10. 1016/j. ejpb. 2012. 01. 016. Review.
4. Qin X-H, Wang S-Y. Filtration properties of electrospinning nanofibers. J Appl Poly Sci. 2006; 102: 1285-90. doi: 10. 1002/app. 24361.
5. Pham QP, Sharma U, Mikos AG. Electrospinning of polymeric nanofibers for tissue engineering applications: a review. Tissue Eng. 2006; 12: 1197-211. doi: 10. 1089/ten. 2006. 12. 1197. Review.
6. Dahlin RL, Kasper FK, Mikos AG. Polymeric nanofibers in tissue engineering. Tissue Eng B-Rev. 2011; 17: 349-64. doi: 10. 1089/ten. teb. 2011. 0238. Review.
7. Buschle-Diller G, Cooper J, Xie Z, Wu Y, Waldrup J, Ren X. Release of antibiotics from electrospun bicomponent fibres. Cellulose. 2007; 14: 553-62.
8. Ramakrishna S, Fujihara K, Teo WE, Lim TC, Ma Z. An introduction to electrospinning and nanofibres. London: World Scientific; 2005. p. 276.
9. Ji W, Sun Y, Yang F, van den Beucken JJJP, Fan MW, Chen Z, et al. Bioactive electrospun scaffolds delivering growth factors and genes for tissue engineering applications. Pharm Res. 2011; 28: 1259-72.
10. Thakur RA, Florek CA, Kohn J, Michniak BB. Electrospun nanofibrous polymeric scaffold with targeted drug release profiles for potential application as wound dressing. Int J Pharm. 2008; 364: 87-93.
11. Xie J, Wang C-H. Electrospun micro- and nanofibers for sustained delivery of paclitaxel to treat C6 glioma in vitro. Pharm Res. 2006; 23: 1817-26.
12. Bickers DR, Lim HW, Margolis D, Weinstock MA, Goodman C, Faulkner E, et al. The burden of skin diseases: 2004-a joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology. J Am Acad Dermatol. 2006; 55: 490-500.
13. Monaco JL, Lawrence WT. Acute wound healing - an overview. Clinics Plastic Surg. 2003; 30: 1-12.
14. Moore K, McCallion R, Searle RJ, Stacey MC, Harding KG. Prediction and monitoring the therapeutic response of chronic dermal wounds. Int Wound J. 2006; 3: 89-96.
15. Singh AV, Aditi AS, Gade WN, Vats T, Lenardi C, Milani P. Nanomaterials: new generation therapeutics in wound healing and tissue repair. Curr Nanosci. 2010; 6: 577-86. Review.
16. Schneider A, Wang XY, Kaplan DL, Garlick JA, Egles C. Biofunctionalized electrospun silk mats as a topical bioactive dressing for accelerated wound healing. Acta Biomater. 2009; 5: 2570-8.
17. Lee W, Debasitis JC, Lee VK, Lee J-H, Fischer K, Edminster K, et al. Multi-layered culture of human skin fibroblasts and keratinocytes through three-dimensional freeform fabrication. Biomaterials. 2009; 30: 1587-95.
18. Kenawy ER, Bowlin GL, Mansfield K, Layman J, Simpson DG, Sanders EH, et al. Release of tetracycline hydrochloride from electrospun poly(ethylene-co-vinylacetate), poly(lactic acid), and a blend. J Control Release. 2002; 81: 57-64.
19. Kanawung K, Panitchanapan K, Puangmalee S-O, Utok W, Kreua-Ongarjnukool N, Rangkupan R, et al. Preparation and characterization of polycaprolactone/diclofenac sodium and poly(vinyl alcohol)/tetracycline hydrochloride fiber mats and their release of the model drugs. Polymer J. 2007; 39: 369-78.
20. Katti DS, Robinson KW, Ko FK, Laurencin CT. Bioresorbable nanofiber-based systems for wound healing and drug delivery: optimization of fabrication parameters. J Biomed Mater Res Part B. 2004; 70B: 286-96.
21. Xu XL, Zhong W, Zhou SF, Trajtman A, Alfa M. Electrospun PEG-PLA nanofibrous membrane for sustained release of hydrophilic antibiotics. J Appl Polym Sci. 2010; 118: 588-95.
22. Su Y, Li XQ, Wang HS, He CL, Mo XM. Fabrication and characterization of biodegradable nanofibrous mats by mix and coaxial electrospinning. J Mater Sci Mater Med. 2009; 20: 2285-94.
23. Qi R, Guo R, Shen M, Cao X, Zhang L, Xu J, et al. Electrospun poly(lactic-co-glycolic acid)/halloysite nanotube composite nanofibers for drug encapsulation and sustained release. J Mater Chem. 2010; 20: 10622-9.
24. Fujihara K, Kotaki M, Ramakrishna S. Guided bone regeneration membrane made of polycaprolactone/calcium carbonate composite nano-fibers. Biomaterials. 2005; 26: 4139-47.
25. Kidoaki S, Kwon IK, Matsuda T. Mesoscopic spatial designs of nano- and microfiber meshes for tissue-engineering matrix and scaffold based on newly devised multilayering and mixing electrospinning techniques. Biomaterials. 2005; 26: 37-46.
26. Venugopal JR, Zhang YZ, Ramakrishna S. In vitro culture of human dermal fibroblasts on electrospun polycaprolactone collagen nanofibrous membrane. Artif Organs. 2006; 30: 440-6.
27. Choi JS, Leong KW, Yoo HS. In vivo wound healing of diabetic ulcers using electrospun nanofibers immobilized with human epidermal growth factor (EGF). Biomaterials. 2008; 29: 587-96.
28. Hayami JWS, Surrao DC, Waldman SD, Amsden BG. Design and characterization of a biodegradable composite scaffold for ligament tissue engineering. J Biomed Mater Res A. 2010; 92A: 1407-20.
29. Tallury P, Alimohammadi N, Kalachandra S. Poly(ethylene-co-vinyl acetate) copolymer matrix for delivery of chlorhexidine and acyclovir drugs for use in the oral environment: effect of drug combination, copolymer composition and coating on the drug release rate. Dent Mater. 2007; 23: 404-9.
30. Boyle VJ, Fancher ME, Ross RW. Rapid, modified Kirby-Bauer susceptibility test with single, high-concentration antimicrobial disks. Antimicrob Agents Chemother. 1973; 3: 418-24.
31. Collins G, Federici J, Imura Y, Catalani LH. Charge generation, charge transport, and residual charge in the electrospinning of polymers: a review of issues and complications. J Appl Phys. 2012; 111. doi: 10. 1063/1. 3682464. Review.
32. Ramakrishna S, Fujihara K, Teo WE, Lim TC, Ma Z. An introduction to electrospinning and nanofibres. London: World Scientific; 2005. p. 109.
33. Walton VC, Howlett MR, Selzer GB. Anhydrotetracycline and 4-epianhydrotetracycline in market tetracyclines and aged tetracycline products. J Pharm Sci. 1970; 59: 1160-x. doi: 10. 1002/jps. 2600590822.
34. 1H nuclear magnetic resonance spectroscopy. J Pharm Biomed Anal. 1983; 1: 281-92.
35. 1H NMR spectroscopy. Mag Res Chem. 1985; 23: 767-70. doi: 10. 1002/mrc. 1260230917.
36. Kim K, Luu YK, Chang C, Fang DF, Hsiao BS, Chu B, et al. Incorporation and controlled release of a hydrophilic antibiotic using poly(lactide-co-glycolide)-based electrospun nanofibrous scaffolds. J Control Release. 2004; 98: 47-56.
37. Taepaiboon P, Rungsardthong U, Supaphol P. Drug-loaded electrospun mats of poly(vinyl alcohol) fibres and their release characteristics of four model drugs. Nanotechnology. 2006; 17: 2317-29. doi: 10. 1088/0957-4484/17/9/041.
38. Jiang H, Hu Y, Li Y, Zhao P, Zhu K, Chen W. A facile technique to prepare biodegradable coaxial electrospun nanofibers for controlled release of bioactive agents. J Control Release. 2005; 108: 237-43. doi: 10. 1016/j. jconrel. 2005. 08. 006.
39. Woodruff MA, Hutmacher DW. The return of a forgotten polymer-polycaprolactone in the 21st century. Prog Polym Sci. 2010; 35: 1217-56.
40. Wang X, Wang Y, Wei K, Zhao N, Zhang S, Chen J. Drug distribution within poly(ε-caprolactone) microspheres and in vitro release. J Mater Process Technol. 2009; 209: 348-54.
41. Pérez MH, Zinutti C, Lamprecht A, Ubrich N, Astier A, Hoffman M, et al. The preparation and evaluation of poly(∈-caprolactone) microparticles containing both a lipophilic and a hydrophilic drug. J Control Release. 2000; 65: 429-38.
42. Salyer IO, Kenyon AS. Structure and property relationships in ethylene-vinyl acetate copolymers. J Polym Sci A-1. 1971; 9: 3083-103.
43. Young TH, Lin DT, Chen LY. Human monocyte adhesion and activation on crystalline polymers with different morphology and wettability in vitro. J Biomed Mater Res. 2000; 50: 490-8.
44. Zhu YB, Gao CY, Liu XY, Shen JC. Surface modification of polycaprolactone membrane via aminolysis and biomacromolecule immobilization for promoting cytocompatibility of human endothelial cells. Biomacromolecules. 2002; 3: 1312-9. doi: 10. 1021/bm020074y.
45. Miller ES, Peppas NA, Winslow DN. Morphological changes of ethylene/vinyl acetate-based controlled delivery systems during release of water-soluble solutes. J Membrane Sci. 1983; 14: 79-92. doi: 10. 1016/S0376-7388(00)81375-7.
46. Di Colo G. Controlled drug release from implantable matrices based on hydrophobic polymers. Biomaterials. 1992; 13: 850-6. Review.
47. Zilberman M, Elsner JJ. Antibiotic-eluting medical devices for various applications. J Control Release. 2008; 130: 202-15.
48. Kim G, Yoon H, Park Y. Drug release from various thicknesses of layered mats consisting of electrospun polycaprolactone and polyethylene oxide micro/nanofibres. Appl Phys A Mater Sci Process. 2010; 100: 1197-204.
49. Park S-C, Kim M-H, Hossain MA, Shin SY, Kim Y, Stella L, et al. Amphipathic α-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions. Biochim Biophys Acta. 2008; 1778: 229-41. doi: 10. 1016/j. bbamem. 2007. 09. 020.
50. Yoon H, Kim G. A three-dimensional polycaprolactone scaffold combined with a drug delivery system consisting of electrospun nanofibres. J Pharm Sci. 2011; 100: 424-30.
51. Yoon H, Kim GH. Layer-by-layered electrospun micro/nanofibrous mats for drug delivery system. Macromol Res. 2012; 20: 402-6.